Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc.APUS · Entity 8263 | Director | November 11, 2025 | November 13, 2025 |
| SONO TEK CORPSOTK · Entity 6933 | Director | August 20, 2026 | August 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Apimeds Pharmaceuticals US, Inc.
Report date November 11, 2025 · Filed November 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.67 · Expires 2035-11-11 | Direct | 10,000 |
Reported balance
After 2025-11-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-11 · Grant · Acquired 10,000 · Balance 10,000 F1: The shares of common stock subject to the option shall vest in quarterly installments beginning October 1, 2025, such that the award shall be fully vested after three years subject to the reporting person's employment continuing through and on each vesting date. This option is not exercisable until stockholder approval is obtained to approve an amendment to the Company's incentive plan (the "Plan") to increase the number of shares of common stock available for issuance under the Plan. The shares of common stock subject to the option shall vest in full vest upon the occurrence of a Change in Control, as defined in the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of common stock subject to the option shall vest in quarterly installments beginning October 1, 2025, such that the award shall be fully vested after three years subject to the reporting person's employment continuing through and on each vesting date. This option is not exercisable until stockholder approval is obtained to approve an amendment to the Company's incentive plan (the "Plan") to increase the number of shares of common stock available for issuance under the Plan. The shares of common stock subject to the option shall vest in full vest upon the occurrence of a Change in Control, as defined in the Plan.
SONO TEK CORP
Report date August 20, 2026 · Filed August 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Sono-Tek OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $5.35 · Expires 2036-08-20 | Direct | 30,773 |
Reported balance
After 2026-08-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-20 · Grant · Acquired 5,396 · Balance 30,773 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2026 Filed Aug 24, 2026 20:15 UTC | SONO TEK CORP SOTK · Entity 6933 | GrantSono-Tek Options · Derivative | 5,396 | $5.35 Strike: $5.35 | $28,868.60 |
DisclosureSEC source: 0001171520-26-000252 · doc4_1166.xml · derivative · entry 1 O'DONNELL CAROL A · CIK 0001573840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,773 Underlying: Sono-Tek Corp Common Stock · 5,396 shares Expires 2036-08-20 Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 23:34 UTC | Apimeds Pharmaceuticals US, Inc. APUS · Entity 8263 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.67 | $0.00 |
DisclosureSEC source: 0001573840-25-000003 · primary_doc.xml · derivative · entry 1 O'DONNELL CAROL A · CIK 0001573840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock, par value $0.01 per share · 10,000 shares Expires 2035-11-11 F1 · derivative.exercise_date: The shares of common stock subject to the option shall vest in quarterly installments beginning October 1, 2025, such that the award shall be fully vested after three years subject to the reporting person's employment continuing through and on each vesting date. This option is not exercisable until stockholder approval is obtained to approve an amendment to the Company's incentive plan (the "Plan") to increase the number of shares of common stock available for issuance under the Plan. The shares of common stock subject to the option shall vest in full vest upon the occurrence of a Change in Control, as defined in the Plan. Read SEC document |
| October 15, 2025 Filed Oct 21, 2025 12:25 UTC | Apimeds Pharmaceuticals US, Inc. APUS · Entity 8263 | GrantStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0001573840-25-000002 · primary_doc.xml · derivative · entry 1 O'DONNELL CAROL A · CIK 0001573840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock, par value $0.01 per share · 3,000 shares Expires 2035-10-15 F1 · derivative.exercise_date: The shares of common stock subject to the option shall vest in quarterly installments beginning October 1, 2025, such that the award shall be fully vested after three years subject to the reporting person's service to the issuer continuing through and on each vesting date. This option is not exercisable until stockholder approval is obtained to approve an amendment to the issuer's incentive plan (the "Plan") to increase the number of shares of common stock available for issuance under the Plan. The shares of common stock subject to the option shall vest in full upon the occurrence of a Change in Control, as defined in the Plan. Read SEC document |
| August 21, 2025 Filed Aug 25, 2025 20:30 UTC | SONO TEK CORP SOTK · Entity 6933 | GrantSono-Tek Options · Derivative | 7,018 | $3.25 Strike: $3.25 | $22,808.50 |
DisclosureSEC source: 0001420506-25-002396 · doc4_1166.xml · derivative · entry 1 O'DONNELL CAROL A · CIK 0001573840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,377 Underlying: Sono-Tek Corp Common Stock · 7,018 shares Expires 2035-08-21 Read SEC document |
| May 16, 2025 Filed May 20, 2025 21:02 UTC | Apimeds Pharmaceuticals US, Inc. APUS · Entity 8263 | GrantStock Option (right to buy) · Derivative | 5,780 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001474506-25-000101 · primary_doc.xml · derivative · entry 1 O'DONNELL CAROL A · CIK 0001573840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,780 Underlying: Common Stock, par value $0.01 per share · 5,780 shares Expires 2035-05-16 F1 · derivative.exercise_date: The option will vest in full and become exercisable on 05/16/2026. Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 19:02 UTC | SONO TEK CORP SOTK · Entity 6933 | GrantSono-Tek Corp Options · Derivative | 5,333 | $4.12 Strike: $4.12 | $21,971.96 |
DisclosureSEC source: 0001573840-24-000001 · primary_doc.xml · derivative · entry 1 O'DONNELL CAROL A · CIK 0001573840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,359 Underlying: Sono-Tek Corp Common Stock · 5,333 shares Expires 2034-08-22 Read SEC document |
| August 24, 2023 Filed Aug 28, 2023 19:22 UTC | SONO TEK CORP SOTK · Entity 6933 | GrantSono-Tek Corp Options · Derivative | 3,676 | $4.79 Strike: $4.79 | $17,608.04 |
DisclosureSEC source: 0001573840-23-000001 · primary_doc.xml · derivative · entry 1 O'DONNELL CAROL A · CIK 0001573840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,026 Underlying: Sono-Tek Corp Common Stock · 3,676 shares Expires 2033-08-24 F1 · derivative.exercise_date: Subject to vesting schedule. Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 21:22 UTC | SONO TEK CORP SOTK · Entity 6933 | GrantSono-Tek Corp Options · Derivative | 3,300 | $5.50 Strike: $5.50 | $18,150.00 |
DisclosureSEC source: 0001573840-22-000002 · primary_doc.xml · derivative · entry 1 O'DONNELL CAROL A · CIK 0001573840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,350 Underlying: Sono-Tek Corp Common Stock · 3,300 shares Expires 2032-08-18 F1 · derivative.exercise_date: Subject to vesting schedule. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 22:21 UTC | SONO TEK CORP SOTK · Entity 6933 | PurchaseSono-Tek Corp Common Stock | 200 | $5.25 | $1,050.00 |
DisclosureSEC source: 0001573840-22-000001 · primary_doc.xml · nonDerivative · entry 3 O'DONNELL CAROL A · CIK 0001573840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 22:21 UTC | SONO TEK CORP SOTK · Entity 6933 | PurchaseSono-Tek Corp Common Stock | 100 | $5.24 | $524.00 |
DisclosureSEC source: 0001573840-22-000001 · primary_doc.xml · nonDerivative · entry 2 O'DONNELL CAROL A · CIK 0001573840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,800 Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 22:21 UTC | SONO TEK CORP SOTK · Entity 6933 | PurchaseSono-Tek Corp Common Stock | 1,700 | $5.21 | $8,857.00 |
DisclosureSEC source: 0001573840-22-000001 · primary_doc.xml · nonDerivative · entry 1 O'DONNELL CAROL A · CIK 0001573840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,700 Read SEC document |
| December 14, 2021 Filed Dec 14, 2021 21:54 UTC | SONO TEK CORP SOTK · Entity 6933 | Exercise / conversionSono-Tek Corp Options · Derivative | 20,000 | $3.00 Strike: $3.00 | $60,000.00 |
DisclosureSEC source: 0001573840-21-000002 · primary_doc.xml · derivative · entry 2 O'DONNELL CAROL A · CIK 0001573840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,050 Underlying: Sono-Tek Corp Common Stock · 20,000 shares Expires 2028-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reporting person exercised 20,000 vested options. Read SEC document |
| December 14, 2021 Filed Dec 14, 2021 21:54 UTC | SONO TEK CORP SOTK · Entity 6933 | Exercise / conversionSono-Tek Corp Common Stock | 20,000 | $3.00 | $60,000.00 |
DisclosureSEC source: 0001573840-21-000002 · primary_doc.xml · nonDerivative · entry 1 O'DONNELL CAROL A · CIK 0001573840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reporting person exercised 20,000 vested options. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 16:57 UTC | SONO TEK CORP SOTK · Entity 6933 | GrantSono-Tek Corp Options · Derivative | 6,050 | $3.19 Strike: $3.19 | $19,299.50 |
DisclosureSEC source: 0001573840-21-000001 · primary_doc.xml · derivative · entry 1 O'DONNELL CAROL A · CIK 0001573840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,050 Underlying: Sono-Tek Corp Common Stock · 6,050 shares Expires 2031-08-19 F1 · derivative.exercise_date: Subject to vesting. Read SEC document |
| November 15, 2018 Filed Nov 20, 2018 00:44 UTC | SONO TEK CORP SOTK · Entity 6933 | GrantSono-Tek Corp Options · Derivative | 20,000 | $3.00 Strike: $3.00 | $60,000.00 |
DisclosureSEC source: 0001573840-18-000002 · primary_doc.xml · derivative · entry 1 O'DONNELL CAROL A · CIK 0001573840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Sono-Tek Corp Common Stock · 20,000 shares Expires 2028-11-15 F1 · derivative.exercise_date: Subject to vesting schedule. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.